Leadership Transition at Bayer AG: From Wolfgang Nickl to Judith Hartmann

A Transformational Tenure

“Today marked my ninth Annual General Meeting with Team Bayer - and my last as CFO,” Nickl stated, underscoring the significance of the moment. Over his tenure, he played a central role in reshaping Bayer’s financial and operational structure during a period marked by both strategic challenges and opportunities.

Nickl emphasized that Bayer is now “in a much stronger position than a few years ago.” He highlighted several key achievements: a leaner and more focused organization, a strengthened innovation pipeline, reduced debt levels, and tangible progress in addressing complex litigation issues. These developments, he noted, have positioned the company firmly on the path to recovery, with its turnaround “well underway.”

As he prepares to step down at the end of May 2026, Nickl expressed optimism about Bayer’s prospects. He pointed to the company’s “meaningful mission,” “clear strategy,” and the strength of its leadership and workforce as critical drivers for future success. His message to shareholders and employees alike was one of confidence and continuity.

Welcoming a Globally Experienced Successor

Effective June 1, 2026, Judith Hartmann will assume the role of Chief Financial Officer, following her appointment to the Board of Management earlier in March.

Hartmann brings a wealth of international experience across multiple industries, including energy, media, and technology. She most recently served as an Operating Partner at Sandbrook Capital, a firm focused on climate infrastructure investments. Prior to that, she held senior leadership roles at ENGIE, where she served as Chief Financial Officer and Deputy CEO, and at Bertelsmann as Group CFO.

Earlier in her career, Hartmann spent over a decade at General Electric, holding a range of financial and operational roles across the United States, Europe, and Latin America. Her experience spans diverse sectors, including healthcare, energy, and media, equipping her with a broad strategic perspective.

A Profile of Strategic and Transformational Leadership

The Chairman of Bayer’s Supervisory Board, Norbert Winkeljohann, praised Hartmann as “a highly accomplished leader with vast international experience,” noting her proven ability to guide organizations through transformation while identifying new growth opportunities.

Beyond her executive roles, Hartmann has built an extensive portfolio as a non-executive director. She has served on the boards of major global companies, including Unilever, Marsh McLennan, and Ørsted, among others. This governance experience further strengthens her profile as she steps into one of Bayer’s most critical leadership positions.

Continuity and Momentum

The transition from Nickl to Hartmann comes at a pivotal moment for Bayer. The company’s restructuring efforts, financial discipline, and strategic clarity have laid the groundwork for the next phase of its turnaround.

Nickl’s legacy is one of stabilization and structural reform—building a solid financial foundation under challenging circumstances. Hartmann, in turn, is expected to build on this foundation, leveraging her international experience and transformational leadership to drive the company’s next chapter.

As Bayer looks ahead, the message from its outgoing CFO remains clear: the company’s turnaround is not only underway, but its future potential is substantial. With new leadership stepping in and a strengthened organization in place, Bayer appears poised to translate its progress into sustained performance.

Sophie Stevenard